Association of TRILEPTAL (oxcarbazepine) with Life-Threatening Dermatological Reactions and Multi-Organ Hypersensitivity – Novartis Pharmaceuticals Canada Inc. – For Health Professionals
Critical priority
The issue
New safety information
Where it was sold
ONReported in the official notice — confirm there.
Issued by
Health Canada — Marketed health products
Read the official Government of Canada notice
All recallsRecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.